Jury rejects foreign sovereign compulsion defense in Vitamin C litigation.

In the Vitamin C litigation I mentioned several weeks back, the jury found for the plaintiffs, rejecting the Chinese companies' foreign sovereign compulsion defense. The jury found that the plaintiffs suffered $54M in damages, which is trebled (tripled) in antitrust law. Hence, the plaintiffs were awarded over $162M in damages. This might serve as interesting precedent in subsequent litigation involving Chinese companies and how their conduct affects American companies and consumers.